Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.31) per share. This is a 38 percent increase over losses of $(0.50) per share from the same period last year.
Wells Fargo Maintains Overweight on Twilio, Lowers Price Target to $180
Wells Fargo analyst Michael Turrin maintains Twilio (NYSE:TWLO) with a Overweight and lowers the price target from $225 to $180.